Ravin Ratan

Ravin Ratan is a Senior Professor at The University of Texas MD Anderson Cancer Center, where he specializes in sarcoma and radiation oncology. His research focuses on multimodal cancer treatment, systemic therapy optimization, and the molecular pathology of soft tissue and bone sarcomas, including leiomyosarcoma, Ewing sarcoma, and dedifferentiated liposarcoma. Recent work includes phase I/II trials of novel agents such as the DR5 agonist ozekibart and the EZH2 inhibitor tazemetostat, as well as long-term outcomes from the DeFi trial on nirogacestat for desmoid tumors. His publications appear in Nature Communications, Journal of Clinical Oncology, and Cancers, reflecting his leadership in translational sarcoma research and international collaborative trials.